| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 2360.0 | 2551.1 | 2188.7 |
| Other income | 0.6 | 0.7 | 1.6 |
| Total income | 2360.6 | 2551.8 | 2190.2 |
| Profit before exceptional items & tax | 99.5 | 88.2 | 70.4 |
| Exceptional items | 0.0 | 0.8 | 0.0 |
| Profit before tax | 112.5 | 90.6 | 81.8 |
| Net profit | 86.9 | 67.6 | 64.0 |
| Operating margin | 4.8% | 3.6% | 3.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +35.80% |
|---|---|
| Net profit, quarter on quarter | +28.60% |
| Revenue, year on year | +7.80% |
BSE results filing, NSE: INDIAGLYCO. Figures extracted from the filing.
India Glycols Ltd: key numbers
- Share price
- ₹382.70
- Market cap
- ₹2,565 Cr
- Revenue (annual)
- ₹4,211 Cr
- Net profit (annual)
- ₹292.8 Cr
- P/E (TTM)
- 8.1×Sector 36.8×
- Promoter holding
- 59.63%+0.00% QoQ
- FII holding
- 2.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from India Glycols Ltd
All →India Glycols Board Meeting Outcome
India Glycols Limited announced that its subsidiary, IGL Spirits Limited, approved share allotment under a Scheme of Arrangement and appointed new key managerial personnel.
India Glycols Management Change
India Glycols Ltd announced that four senior management personnel ceased their roles following the effective date of a previously disclosed Scheme of Arrangement.
India Glycols Merger & Restructuring
India Glycols Limited has completed its demerger into three separate entities effective September 1, 2026. The scheme, sanctioned by the NCLT, is now operational.
India Glycols Management Change
India Glycols' subsidiary, Ennature Bio Pharma, announced the appointment of new Directors and a Managing Director. These appointments are part of ongoing corporate updates.
India Glycols Merger & Restructuring
India Glycols Ltd received the certified NCLT order approving the Scheme of Arrangement, which involves the demerger of its Biopharma, Spirits, and Biofuel undertakings.
India Glycols Annual General Meeting
India Glycols held its 42nd Annual General Meeting on August 19, 2026. Shareholders approved all resolutions, including the final dividend payout.